In the relentless battle against drug-resistant bacteria, a new class of antibiotics is emerging as a beacon of hope.Kinvard Bio, a visionary startup born from the esteemed Myers Lab at Harvard University, is pioneering innovative solutions aimed at tackling the growing epidemic of antibiotic resistance.